About

About Agilent Advanced Therapeutics, fka BIOVECTRA Agilent Advanced Therapeutics is Agilent’s contract development and manufacturing organization (CDMO), bringing together BIOVECTRA’s proven expertise in biologics fermentation, complex chemistry, highly potent APIs, and bioreagents, with Agilent’s Nucleic Acid Solutions Division capabilities in oligonucleotides and advanced nucleic acid manufacturing. Together, these complementary strengths create a unified CDMO partner supporting advanced therapeutics from development through commercial supply. Combining white-glove service, deep scientific expertise, and long-term investment, Agilent Advanced Therapeutics delivers customized end-to-end solutions designed around each client’s needs. Backed by rigorous, data-driven processes and Agilent’s global quality systems, our scientists work alongside yours to help move programs forward with confidence. Invested in science, invested in your success.